208 related articles for article (PubMed ID: 15947127)
1. Blueprint for implementing USP chapter 797 for compounding sterile preparations.
Kastango ES;
Am J Health Syst Pharm; 2005 Jun; 62(12):1271-88. PubMed ID: 15947127
[TBL] [Abstract][Full Text] [Related]
2. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
Formea CM; Weiss WT; McCluskey SV
Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
[TBL] [Abstract][Full Text] [Related]
3. USP general chapter <797> pharmaceutical compounding-sterile preparations.
Hung JC
J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
[No Abstract] [Full Text] [Related]
4. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
5. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
6. USP publishes enforceable chapter on sterile compounding.
Thompson CA
Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
[No Abstract] [Full Text] [Related]
7. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
Cooper JF; Latta KS; Smith D
Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
[TBL] [Abstract][Full Text] [Related]
8. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
Hyde TD
Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
[TBL] [Abstract][Full Text] [Related]
9. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
[TBL] [Abstract][Full Text] [Related]
10. Impact of United States Pharmacopeia chapter 797: results of a national survey.
Candy TA; Schneider PJ; Pedersen CA
Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
[TBL] [Abstract][Full Text] [Related]
11. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
Allen LV
Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
[TBL] [Abstract][Full Text] [Related]
12. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
Peters GF; McKeon MR; Weiss WT
Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
[TBL] [Abstract][Full Text] [Related]
13. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
Martin M
Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
[TBL] [Abstract][Full Text] [Related]
14. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
Marks Z
Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
[TBL] [Abstract][Full Text] [Related]
15. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
Kastango ES; Bradshaw BD
Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
[No Abstract] [Full Text] [Related]
16. Revisions continue on USP sterile-compounding chapter.
Thompson CA
Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
[No Abstract] [Full Text] [Related]
17. Microbiologic Testing for 503A Sterile-Compounding Pharmacies.
Mixon W; Roth A
Int J Pharm Compd; 2017; 21(3):193-203. PubMed ID: 28557780
[TBL] [Abstract][Full Text] [Related]
18. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1.
Martin M
Int J Pharm Compd; 2018; 22(5):401-404. PubMed ID: 30384338
[TBL] [Abstract][Full Text] [Related]
19. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
[TBL] [Abstract][Full Text] [Related]
20. USP releases revision of chapter on sterile compounding: new version of USP chapter 797 emphasizes personnel.
Thompson CA
Am J Health Syst Pharm; 2008 Jan; 65(2):104, 111. PubMed ID: 18192250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
